Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada

Canadian Journal of Public Health

Volumn 105, Issue 3, 2014, Pages

  Kouyoumdjian, Fiona G ^a,b   Calzavara, Liviana M ^a   Kiefer, Lori ^a,c   Main, Cheryl ^d   Bondy, Susan J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Ministry of Community Safety and Correctional Services   (Canada)

^d HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

Drug use disorders; Prisons; Street drugs; Substance use disorders

Indexed keywords

STREET DRUG;

ADOLESCENT; ADULT; BLOODBORNE BACTERIUM; CANADA; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRISON; PRISONER; PSYCHOLOGY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD-BORNE PATHOGENS; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ONTARIO; PREVALENCE; PRISONERS; PRISONS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 84904090037     PISSN: 00084263     EISSN: 19207476     Source Type: Journal    
DOI: 10.17269/cjph.105.4193     Document Type: Article

References (33)

1. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: A systematic review. Addiction 2006; 101(2): 181-91.
2. Fazel S, Baillargeon J. The health of prisoners. Lancet 2011; 377(9769): 956-65.
3. Kanato M. Drug use and health among prison inmates. Curr Opin Psychiatr 2008; 21: 252-54.
4. Kinner SA, Forsyth S, Williams G. Systematic review of record linkage studies of mortality in ex-prisoners: Why (good) methods matter. Addiction 2013; 108(1): 38-49.
5. Statistics Canada. Adult Correctional Services, Admissions to Provincial, Territorial and Federal Programs (Canada). 2012. Available at: http: //www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/legal30aeng. htm (Accessed November 4, 2013).
6. Zakaria D, Thompson JM, Jarvis A, Borgatta F. Summary of Emerging Findings from the 2007 National Inmate Infectious Diseases and Risk-Behaviours Survey. Correctional Service Canada, 2010.
7. Johnson S, MacDonald SF, Cheverie M, Myrick C, Fischer B. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada. Drug Alcohol Depend 2012; 124(1-2): 172-76.
8. Ford PM, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM 2000; 93(2): 113-19.
9. Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003; 98(9): 1257-65.
10. Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ 2007; 177(3): 257-61.
11. Buxton JA, Rothon D, Durigon M, Lem M, Tu AW, Remple VP, et al. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia. Can J Public Health 2009; 100(2): 121-24.
12. Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996; 10(9): 1009-15.
13. Martin RE, Gold F, Murphy W, Remple V, Berkowitz J, Money D. Drug use and risk of bloodborne infections: A survey of female prisoners in British Columbia. Can J Public Health 2005; 96(2): 97-101.
14. Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. CMAJ 2007; 177(3): 252-56.
15. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Switzerland: World Health Organization, 2009.
16. Shoptaw S, Montgomery B, Williams CT, El-Bassel N, Aramrattana A, Metsch L, et al. Not just the needle: The state of HIV-prevention science among substance users and future directions. J Acquire Immune Defic Syndr 2013; 63(Suppl 2): S174-78.
17. Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev 2010; (1): CD007192.
18. Ford PM, Alifo A, Connop PJ, Panaro L, Zoutman D. Seroprevalence of HIV-1 in a male medium security penitentiary-Ontario. Can Commun Dis Rep 1994; 20(6): 45-47.
19. Kouyoumdjian FG, Main C, Calzavara LM, Kiefer L. Prevalence and predictors of urethral chlamydia and gonorrhea infection in male inmates in an Ontario correctional facility. Can J Public Health 2011; 102(3): 220-24.
20. Prefontaine RG, Chaudhary RK. Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia. Can Dis Wkly Rep 1990; 16(52): 265-66.
21. Pearson M, Mistry PS, Ford PM. Voluntary screening for hepatitis C in a Canadian federal penitentiary for men. Can Commun Dis Rep 1995; 21(14): 134-36.
22. Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, et al. Seroprevalence of hepatitis C in a Canadian federal penitentiary for women. Can Commun Dis Rep 1995; 21(14): 132-34.
23. Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995; 153(11): 1605-9.
24. Werb D, Kerr T, Small W, Li K, Montaner J, Wood E. HIV risks associated with incarceration among injection drug users: Implications for prisonbased public health strategies. J Public Health 2008; 30(2): 126-32.
25. Fischer B, Rehm J, Patra J, Cruz MF. Changes in illicit opioid use across Canada. CMAJ 2006; 175(11): 1385.
26. Remis R. Modelling the incidence and prevalence of hepatitis C infection and its sequelae in Canada, 2007. Ottawa, ON: Public Health Agency of Canada, 2007.
27. Small W, Kain S, Laliberte N, Schechter MT, O'Shaughnessy MV, Spittal PM. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Subst Use Misuse 2005; 40(6): 831-43.
28. Juergens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis 2009; 9(1): 57-66.
29. Dembo R, Dertke M, La Voie L, Borders S, Washburn M, Schmeidler J. Physical abuse, sexual victimization and illicit drug use: A structural analysis among high risk adolescents. J Adolesc 1987; 10(1): 13-34.
30. Galea S, Vlahov D. Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Rep 2002; 117(Suppl 1): S135-45.
31. Ireland JL, Higgins P. Behavioural stimulation and sensation-seeking among prisoners: Applications to substance dependency. Int J Law Psychiatry 2013; 36(3-4): 229-34.
32. Schulz AJ, Krieger J, Galea S. Addressing social determinants of health: Community-based participatory approaches to research and practice. Health Educ Behav 2002; 29(3): 287-95.
33. Haig T. Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison. Can HIV/AIDS Policy Law Rev 2003; 8(3): 48.